Midiana

Drospirenone, the active ingredient in Midiana, is a combined oral contraceptive presented as a unknown/oral tablet for oral use. It treats prevention of pregnancy and menstrual cycle regulation in women of reproductive age.

GNH USA supplies Midiana as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Midiana, a combined oral contraceptive, is used to manage hormonal contraception and menstrual regulation.

- Prevention of pregnancy: provides reliable contraceptive protection by suppressing ovulation. - Menstrual cycle regulation: helps achieve more predictable bleeding patterns. - Management of ovulatory disorders: inhibits luteinizing hormone and follicle‑stimulating hormone release to prevent ovulation.

Midiana may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: discomfort or swelling of breast tissue. - Headache: occasional tension‑type headache. - Spotting or breakthrough bleeding: irregular light bleeding between periods. - Mood changes: irritability or mild mood swings. - Weight gain: modest increase in body weight.

Serious or Rare Side Effects: - Deep vein thrombosis: formation of blood clots in deep veins. - Pulmonary embolism: clot migration to lung vessels. - Stroke or transient ischemic attack: neurological events due to vascular blockage. - Myocardial infarction: heart attack risk, especially in high‑risk groups. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Liver dysfunction: abnormal liver enzyme elevations or jaundice.

Before prescribing Midiana, clinicians should evaluate patient history and risk factors. - Pregnancy contraindication: do not use in women who are or may become pregnant. - Smoking restriction: avoid in women over 35 who smoke more than 15 cigarettes per day. - Thromboembolic history: contraindicated in patients with prior clotting disorders. - Liver disease: use with caution in hepatic impairment. - Hypertension: monitor blood pressure regularly. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Midiana can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may reduce anticoagulant effect. - Enzyme‑inducing antiepileptics (e.g., phenytoin, carbamazepine): lower hormone levels, decreasing contraceptive reliability. - Rifampin or St. John’s wort: strong inducers that diminish oral contraceptive effectiveness.

Moderate Interactions (Monitor Closely): - Certain antifungals (e.g., ketoconazole): may increase hormone concentrations. - SSRIs (e.g., fluoxetine): can heighten bleeding risk. - Diuretics (e.g., spironolactone): may increase serum potassium. - NSAIDs: may elevate blood pressure, requiring monitoring.